Lysine methyltransferase 2D regulates pancreatic carcinogenesis through metabolic reprogramming.

MLA

Koutsioumpa, Marina, et al. “Lysine Methyltransferase 2D Regulates Pancreatic Carcinogenesis through Metabolic Reprogramming.” Gut, vol. 68, no. 7, July 2019, pp. 1271–86. EBSCOhost, https://doi.org/10.1136/gutjnl-2017-315690.

APA

Koutsioumpa, M., Hatziapostolou, M., Polytarchou, C., Tolosa, E. J., Almada, L. L., Mahurkar-Joshi, S., Williams, J., Tirado-Rodriguez, A. B., Huerta-Yepez, S., Karavias, D., Kourea, H., Poultsides, G. A., Struhl, K., Dawson, D. W., Donahue, T. R., Fernández-Zapico, M. E., & Iliopoulos, D. (2019). Lysine methyltransferase 2D regulates pancreatic carcinogenesis through metabolic reprogramming. Gut, 68(7), 1271–1286. https://doi.org/10.1136/gutjnl-2017-315690

Chicago

Koutsioumpa, Marina, Maria Hatziapostolou, Christos Polytarchou, Ezequiel J Tolosa, Luciana L Almada, Swapna Mahurkar-Joshi, Jennifer Williams, et al. 2019. “Lysine Methyltransferase 2D Regulates Pancreatic Carcinogenesis through Metabolic Reprogramming.” Gut 68 (7): 1271–86. doi:10.1136/gutjnl-2017-315690.